Wordt geladen...
Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
PURPOSE: Colistin alone may not be sufficient for treating carbapenem-resistant Acinetobacter baumannii (CRAB); thus, efforts are needed to increase treatment success rates. We compared the effects of colistin plus carbapenem therapy versus colistin monotherapy in treating pneumonia caused by CRAB a...
Bewaard in:
| Gepubliceerd in: | Infect Drug Resist |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6934122/ https://ncbi.nlm.nih.gov/pubmed/31920347 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S234211 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|